Michael Scolaro

Michael Scolaro

Nov 10, 2017

Group 6 Copy 210
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Developing a new treatment for Ebola Virus Disease

Ebola is now a threat of global significance. Fatalities are a consequence of the human body's overreactive...

Viral Causes of Lung Cancer

We have special access to blood specimens collected from more than 9,000 cancer free people. These individuals...

Affordable 3D-Printed Neural Devices for Spinal Cord Regeneration

Medical treatments for spinal cord injuries are expensive and difficult to test. I want to try to develop a...

Backer Badge Funded